ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 45 filers reported holding ADICET BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,000 | -12.5% | 5,102 | +60.6% | 0.00% | – |
| Q2 2023 | $8,000 | -20.0% | 3,176 | +85.0% | 0.00% | – |
| Q1 2023 | $10,000 | -67.7% | 1,717 | -51.2% | 0.00% | – |
| Q4 2022 | $31,000 | +520.0% | 3,515 | +873.7% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 361 | +118.8% | 0.00% | – |
| Q2 2022 | $2,000 | -93.8% | 165 | -89.6% | 0.00% | – |
| Q1 2022 | $32,000 | -52.2% | 1,583 | -58.9% | 0.00% | – |
| Q4 2021 | $67,000 | +191.3% | 3,851 | +32.2% | 0.00% | – |
| Q3 2021 | $23,000 | +27.8% | 2,912 | +69.6% | 0.00% | – |
| Q2 2021 | $18,000 | +63.6% | 1,717 | +119.0% | 0.00% | – |
| Q1 2021 | $11,000 | -15.4% | 784 | -16.0% | 0.00% | – |
| Q4 2020 | $13,000 | +30.0% | 933 | +5.3% | 0.00% | – |
| Q3 2020 | $10,000 | – | 886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |